1-17027759-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_003000.3(SDHB):c.530G>A(p.Arg177His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000177 in 1,584,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R177C) has been classified as Uncertain significance.
Frequency
Consequence
NM_003000.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251384Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135876
GnomAD4 exome AF: 0.0000154 AC: 22AN: 1432242Hom.: 0 Cov.: 26 AF XY: 0.0000210 AC XY: 15AN XY: 714332
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152306Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74470
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies in yeast demonstrate mild impact on SDH activity (Panizza et al., 2013); Observed in individuals with a personal and/or family history of head and neck paraganglioma (Michalowska et al., 2016; Bayley et al., 2020; Richter et al., 2022); Also known as p.R149H; This variant is associated with the following publications: (PMID: 25720320, 25791839, 27867439, 27967220, 31492822, 33152312, 23175444, 25595276, 35171114) -
Hereditary cancer-predisposing syndrome Uncertain:2
- -
The p.R177H variant (also known as c.530G>A), located in coding exon 5 of the SDHB gene, results from a G to A substitution at nucleotide position 530. The arginine at codon 177 is replaced by histidine, an amino acid with highly similar properties. This variant has been reported in multiple individuals diagnosed with paraganglioma or pheochromocytoma, and segregated with disease in one family (von Dobschuetz E et al. Endocr. Relat. Cancer. 2015 Apr;22:191-204; Michaowska I et al. Neuroendocrinology. 2015 Mar;101:321-30; Richter S et al. Endocr Relat Cancer, 2022 Mar;29:213-224); however, this alteration has also been observed in several apparently healthy individuals (Rana HQ et al. Cancers (Basel), 2024 Feb;16; Ambry internal data). Functional studies of this variant demonstrate only a mildly impaired phenotype using a yeast model (Panizza E et al. Hum. Mol. Genet. 2013 Feb;22:804-15). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited and conflicting at this time, the clinical significance of this alteration remains unclear. -
not specified Uncertain:1
- -
Pheochromocytoma;C0238198:Gastrointestinal stromal tumor;C1861848:Paragangliomas 4 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 177 of the SDHB protein (p.Arg177His). This variant is present in population databases (rs150437793, gnomAD 0.006%). This missense change has been observed in individual(s) with paraganglioma-pheochromocytoma (PGL-PCC) syndrome as well as in unaffected individuals (PMID: 25595276, 27867439, 31492822, 35171114; internal data). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 239433). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SDHB protein function with a positive predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on SDHB function (PMID: 23175444). RNA analysis performed to evaluate the impact of this missense change on mRNA splicing indicates it does not significantly alter splicing (internal data). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Paragangliomas 4 Uncertain:1
The SDHB c.530G>A (p.Arg177His) missense change has a maximum frequency of 0.006% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). The in silico tool REVEL predicts a deleterious effect on protein function, and a functional study in yeast demonstrated a mild impact on succinate dehydrogenase function (PMID: 23175444). This variant has been reported in individuals with paragangliomas and pheochromocytomas and was found to segregate in one family (PMID: 25595276, 25791839, 27867439, 35171114). In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Gastrointestinal stromal tumor Uncertain:1
- -
Hereditary pheochromocytoma-paraganglioma Uncertain:1
This missense variant replaces arginine with histidine at codon 177 of the SDHB protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). An experimental functional study in a yeast model demonstrated partial impacts on succinate dehydrogenase function (PMID: 23175444). This variant has been reported in individuals affected with paragangliomas and pheochromocytomas (PMID: 25595276, 25791839, 27867439, 35171114), but also in unaffected individuals (PMID: 25595276, 27867439). The variant has been observed to segregate in one family (PMID: 25595276). This variant has been identified in 8/251384 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at